1.
PCN64 COST-EFFECTIVENESS OF IMATINIB SINCE ITS INTRODUCTION AS FIRST-LINE TREATMENT IN THE NETHERLANDS
2.
The development of a post-mortem interval estimation for human remains found on land in the Netherlands